Clinical Trials Logo

Citation(s)

An Evaluation of the Efficacy of the Tumor Necrosis Factor-alpha Antagonist Infliximab in Treatment Resistant Major Depression: Mechanisms and Mediators

Details for clinical trial NCT00463580